Dolo-650 manufactures face Income Tax raids, searches carried out for alleged tax evasion | Companies News

New Delhi: The Income Tax division Wednesday carried out searches on the premises of Bengaluru-based pharmaceutical firm Micro Labs Ltd, the producers of Dolo-650 pill that was broadly utilized by COVID-19 sufferers over the last over two years, on prices of alleged tax evasion. Officials stated the division is monetary paperwork, stability sheets and enterprise distributor networks of the corporate as a part of the searches.

The PTI has despatched queries on the motion to the corporate and a response is awaited. (ALSO READ: Shares achieve on finance, client increase after in a single day oil selloff)

Some different linked areas of the corporate in different cities and people of its promoters and distributors are additionally being lined, they stated. (ALSO READ: Google India launches Startup School, goals to information 10,000 startups)

The firm stated on its web site that it was engaged within the making and advertising and marketing of pharmaceutical merchandise and APIs (Active Pharmaceutical Ingredients) and has 17 manufacturing items throughout the nation other than conducting enterprise abroad.

Its main pharma merchandise are Dolo-650, Amlong, Lubrex, Diapride, Vildapride, Olmat, Avas, Tripride, Bactoclav, Tenepride-M and Arbitel.

Dolo-650, an analgesic (ache killer) and antipyretic (fever-reducing) was being prescribed by medical doctors and medical store homeowners for coronavirus sufferers to scale back ache and fever, frequent signs brought on by Covid.

In the phrases of the corporate, Dolo-650, is “virtually a household name across the country”.

The firm web site showcased a information article, printed in February, on its web site that stated: “The company has sold 350 crore tablets (of Dolo-650) since the Covid-19 outbreak in 2020, and earned revenues of Rs 400 crore in a year.”

The CMD of the corporate, Dilip Surana, has been quoted within the story.

Source hyperlink

Leave a Reply

Your email address will not be published.